Kane Biotech's Revyve™ Shows Promising Wound Care Results
Winnipeg-based Kane Biotech Inc. reveals groundbreaking clinical data demonstrating Revyve™'s effectiveness in treating chronic wounds, presenting new hope for diabetic foot ulcers and severe burn patients.